MCID: FML307
MIFTS: 40

Familial Calcium Pyrophosphate Deposition

Categories: Bone diseases, Fetal diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Familial Calcium Pyrophosphate Deposition

MalaCards integrated aliases for Familial Calcium Pyrophosphate Deposition:

Name: Familial Calcium Pyrophosphate Deposition 58 29 6
Calcium Pyrophosphate Dihydrate Crystal Deposition Disease 58 54
Hereditary Calcium Pyrophosphate Deposition 58
Calcium Pyrophosphate Deposition Disease 71
Hereditary Articular Chondrocalcinosis 58
Familial Articular Chondrocalcinosis 58
Calcium Pyrophosphate Arthropathy 71
Familial Cppd 58
Hereditary Cc 58
Familial Cc 58

Characteristics:

Orphanet epidemiological data:

58
familial calcium pyrophosphate deposition
Inheritance: Autosomal dominant,Not applicable; Age of onset: Adult; Age of death: normal life expectancy;

Classifications:

Orphanet: 58  
Rare systemic and rhumatological diseases
Rare bone diseases
Developmental anomalies during embryogenesis


External Ids:

ICD10 via Orphanet 33 M11.1
UMLS via Orphanet 72 C0553730 C0856830
Orphanet 58 ORPHA1416
UMLS 71 C0553730 C0856830

Summaries for Familial Calcium Pyrophosphate Deposition

MalaCards based summary : Familial Calcium Pyrophosphate Deposition, also known as calcium pyrophosphate dihydrate crystal deposition disease, is related to chondrocalcinosis 2 and chondrocalcinosis. An important gene associated with Familial Calcium Pyrophosphate Deposition is ANKH (ANKH Inorganic Pyrophosphate Transport Regulator). The drugs Colchicine and Prednisone have been mentioned in the context of this disorder. Affiliated tissues include bone and testes, and related phenotypes are arthralgia and joint swelling

Wikipedia : 74 Calcium pyrophosphate dihydrate (CPPD) crystal deposition disease, also known as pseudogout and... more...

Related Diseases for Familial Calcium Pyrophosphate Deposition

Diseases related to Familial Calcium Pyrophosphate Deposition via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 52)
# Related Disease Score Top Affiliating Genes
1 chondrocalcinosis 2 32.8 OTULIN ANKH
2 chondrocalcinosis 30.1 OTULIN ANKH
3 arthropathy 29.3 CILP ANKH
4 osteoarthritis 10.6
5 gout 10.6
6 hyperparathyroidism 10.6
7 chondrosarcoma 10.5
8 synovial chondromatosis 10.5
9 olecranon bursitis 10.4
10 frozen shoulder 10.4
11 calcinosis 10.4
12 ankylosis 10.4
13 bursitis 10.4
14 spinal stenosis 10.4
15 gilles de la tourette syndrome 10.3
16 osteoporosis 10.3
17 rheumatoid arthritis 10.3
18 sarcoidosis 1 10.3
19 spondylolisthesis 10.3
20 hemochromatosis, type 1 10.3
21 bone mineral density quantitative trait locus 8 10.3
22 bone mineral density quantitative trait locus 15 10.3
23 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.3
24 hyperphosphatemia 10.3
25 scoliosis 10.3
26 osteonecrosis 10.3
27 osteomyelitis 10.3
28 discitis 10.3
29 primary hyperparathyroidism 10.3
30 plica syndrome 10.3
31 hypophosphatasia 10.3
32 rectum adenocarcinoma 10.3
33 hyperostosis 10.3
34 synovitis 10.3
35 systemic scleroderma 10.3
36 radiculopathy 10.3
37 hypokalemia 10.3
38 ulnar neuropathy 10.3
39 hydrarthrosis 10.3
40 nerve compression syndrome 10.3
41 connective tissue disease 10.3
42 adenoma 10.3
43 parathyroid adenoma 10.3
44 septic arthritis 10.3
45 arthritis 10.3
46 subacute delirium 10.3
47 back pain 10.3
48 cerebrofacial arteriovenous metameric syndrome 10.3
49 intermittent hydrarthrosis 10.3
50 pre-descemet corneal dystrophy 10.3

Graphical network of the top 20 diseases related to Familial Calcium Pyrophosphate Deposition:



Diseases related to Familial Calcium Pyrophosphate Deposition

Symptoms & Phenotypes for Familial Calcium Pyrophosphate Deposition

Human phenotypes related to Familial Calcium Pyrophosphate Deposition:

58 31 (show all 11)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 arthralgia 58 31 hallmark (90%) Very frequent (99-80%) HP:0002829
2 joint swelling 58 31 hallmark (90%) Very frequent (99-80%) HP:0001386
3 abnormality of the intervertebral disk 58 31 hallmark (90%) Very frequent (99-80%) HP:0005108
4 calcification of cartilage 58 31 hallmark (90%) Very frequent (99-80%) HP:0100593
5 osteoarthritis 58 31 frequent (33%) Frequent (79-30%) HP:0002758
6 chondrocalcinosis 58 31 occasional (7.5%) Occasional (29-5%) HP:0000934
7 joint dislocation 58 31 occasional (7.5%) Occasional (29-5%) HP:0001373
8 limitation of joint mobility 58 31 occasional (7.5%) Occasional (29-5%) HP:0001376
9 seizure 31 occasional (7.5%) HP:0001250
10 arthritis 58 Very frequent (99-80%)
11 seizures 58 Occasional (29-5%)

Drugs & Therapeutics for Familial Calcium Pyrophosphate Deposition

Drugs for Familial Calcium Pyrophosphate Deposition (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 30)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Colchicine Approved Phase 3 64-86-8 2833 6167
2
Prednisone Approved, Vet_approved Phase 3 53-03-2 5865
3
Povidone Approved Phase 3 9003-39-8
4 Calcium, Dietary Phase 3
5 Antirheumatic Agents Phase 3
6 Hormones Phase 3
7 Antineoplastic Agents, Hormonal Phase 3
8 Hormone Antagonists Phase 3
9 glucocorticoids Phase 3
10 Tubulin Modulators Phase 3
11 Anti-Inflammatory Agents Phase 3
12 Antimitotic Agents Phase 3
13
Calcium Nutraceutical Phase 3 7440-70-2 271
14 Interleukin 1 Receptor Antagonist Protein Phase 2
15
Triamcinolone Approved, Vet_approved 124-94-7 31307
16
Probenecid Approved, Investigational Early Phase 1 57-66-9 4911
17
Methotrexate Approved 59-05-2, 1959-05-2 126941
18
leucovorin Approved 58-05-9 6006 143
19
Folic acid Approved, Nutraceutical, Vet_approved 59-30-3 6037
20 triamcinolone acetonide
21 Triamcinolone hexacetonide
22 Triamcinolone diacetate
23 Immunologic Factors
24 Folic Acid Antagonists
25 Vitamin B Complex
26 Dermatologic Agents
27 Immunosuppressive Agents
28 Folate
29 Antimetabolites
30 Vitamin B9

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Colchicine or Prednisone for the Treatment of Acute Calcium Pyrophosphate Deposition (CPPD) Arthritis: Open-label, Randomized, Multicenter, Equivalence Trial of Efficacy and Safety Recruiting NCT03128905 Phase 3 Colchicine opocalcium 1mg;Prednisone : Cortancyl 20mg
2 Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study Terminated NCT02263638 Phase 2 Anakinra
3 Appraisal of the Diagnostic Rentability of Thorough Analytical Screening Searching Associated Conditions in Patients Newly Diagnosed With Calcium Pyrophosphate Dihydrate Deposition Disease Completed NCT00453128
4 Effects of Local Cryotherapy on Cytokine, VRGF, NFkB and PG-E2 Levels in Knee Arthritis Completed NCT03850392
5 ANK-dependent ATP Efflux Causes Calcium Pyrophosphate Deposition in Cartilage Recruiting NCT02243631 Early Phase 1 Probenecid
6 OMERACT Core Domain Set Selection for Calcium Pyrophosphate Deposition (CPPD): Exploring Patient and Stakeholder Perspectives on Outcome Domains Recruiting NCT04176003
7 A Randomized, Double-blind, Placebo-controlled Clinical Trial of Methotrexate (MTX) in the Treatment of Advanced Knee Osteoarthritis With Effusion-synovitis Recruiting NCT03815448 Methotrexate

Search NIH Clinical Center for Familial Calcium Pyrophosphate Deposition

Genetic Tests for Familial Calcium Pyrophosphate Deposition

Genetic tests related to Familial Calcium Pyrophosphate Deposition:

# Genetic test Affiliating Genes
1 Familial Calcium Pyrophosphate Deposition 29 ANKH

Anatomical Context for Familial Calcium Pyrophosphate Deposition

MalaCards organs/tissues related to Familial Calcium Pyrophosphate Deposition:

40
Bone, Testes

Publications for Familial Calcium Pyrophosphate Deposition

Articles related to Familial Calcium Pyrophosphate Deposition:

(show top 50) (show all 161)
# Title Authors PMID Year
1
Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease. 54 61 6
13130483 2003
2
Craniometaphyseal dysplasia and chondrocalcinosis cosegregating in a family with an ANKH mutation. 6
19449425 2009
3
Mutations in ANKH cause chondrocalcinosis. 6
12297987 2002
4
Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH. 6
12297989 2002
5
Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. 6
11326272 2001
6
Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease. 6
9915952 1999
7
Localisation of a gene for chondrocalcinosis to chromosome 5p. 6
8528213 1995
8
Dominant craniometaphyseal dysplasia--a family study over five generations. 6
2712793 1989
9
The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) affects tissue non-specific Alkaline Phosphatase (TNAP) activities. 54 61
19088867 2008
10
Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease. 61 54
12483726 2002
11
Cartilage intermediate layer protein expression in calcium pyrophosphate dihydrate crystal deposition disease. 54 61
12180739 2002
12
A case of tophaceous pseudogout of the temporomandibular joint extending into the cranium. 61
31559516 2020
13
Cervical CT-Dependent Diagnosis of Crowned Dens Syndrome in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease. 61
31369722 2020
14
Acute odontogenic infection combined with crowned dens syndrome: a case report. 61
31082330 2019
15
Calcium pyrophosphate dihydrate crystal deposition disease and MRSA septic arthritis of the atlantoaxial joint in a patient with Tourette syndrome. 61
30904893 2019
16
Referral Patterns for Dual-Energy Computed Tomography in Diagnosis and Management of Gout: Ten-Year Experience at a Canadian Institution. 61
30249410 2018
17
Calcium pyrophosphate dihydrate crystal deposition disease of the spinal dura mater: a case report. 61
30363166 2018
18
Histology of the synovial membrane of patients affected by osteoarthritis and calcium pyrophosphate dihydrate crystal deposition disease vs. osteoarthritis alone: a pilot study. 61
27093480 2016
19
Calcium Pyrophosphate Dihydrate Crystal Deposition Disease Simulating Osteoarthrosis of the Knee: A Case Report. 61
27660600 2016
20
Tumoral pseudogout of the proximal interphalangeal joint of a finger: a case report and literature review. 61
27048476 2016
21
The prevalence of chondrocalcinosis of the symphysis pubis on CT scan and correlation with calcium pyrophosphate dihydrate crystal deposition disease. 61
26861035 2016
22
The role of ANKH in pathologic mineralization of cartilage. 61
26599446 2016
23
Posterior C1-C2 calcium pyrophosphate dihydrate crystal deposition disease. 61
26976840 2016
24
Diagnostic accuracy of ultrasound, conventional radiography and synovial fluid analysis in the diagnosis of calcium pyrophosphate dihydrate crystal deposition disease. 61
26886247 2016
25
Calcium Pyrophosphate Dihydrate Crystal Deposition Disease of the Sternoclavicular Joint. 61
26693128 2015
26
[Calcium pyrophosphate dihydrate crystal deposition disease as an example of illness presentation in the elderly]. 61
26204548 2015
27
A Rare Case of Tumoral Calcium Pyrophosphate Dihydrate Crystal Deposition Disease of the Wrist Joint. 61
26783477 2015
28
Musculoskeletal Ultrasound Diagnosis in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease. 61
26788360 2014
29
Detection of calcium pyrophosphate dihydrate crystal deposition disease by dual-energy computed tomography. 61
24851080 2014
30
Additive value for ultrasonographic signal in a screening algorithm for patients presenting with acute mono-/oligoarthritis in whom gout is suspected. 61
24510062 2014
31
Imaging characteristics of calcium pyrophosphate dihydrate crystal deposition disease. 61
22561381 2014
32
Upregulation of ANK protein expression in joint tissue in calcium pyrophosphate dihydrate crystal deposition disease. 61
24293574 2014
33
Bilateral Olecranon Bursitis - A Rare Clinical presentation of Calcium Pyrophosphate Crystal Deposition Disease. 61
27298934 2014
34
Calcium pyrophosphate crystal deposition disease: diagnosis and treatment. 61
27790033 2014
35
Calcium pyrophosphate dihydrate crystal deposition disease (pseudogout) of lumbar spine mimicking osteomyelitis-discitis with epidural phlegmon. 61
24078961 2013
36
Calcium pyrophosphate dihydrate deposition disease of the filum terminale. 61
23455952 2013
37
Flexor tendon rupture of the little finger caused by calcium pyrophosphate dihydrate crystal deposition disease of the pisotriquetrum joint. 61
24156589 2013
38
Synovial chondromatosis of the temporomandibular joint with calcium pyrophosphate dihydrate crystal deposition disease (pseudogout). 61
23166363 2012
39
[Calcium pyrophosphate dihydrate crystal deposition disease: a clinicopathologic analysis of 20 cases]. 61
23324232 2012
40
The diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: the good, the bad and… ultrasonography! 61
22842294 2012
41
A case of destructive calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint: a diagnostic challenge. 61
21676588 2011
42
Mimicry in older patients: tophaceous pseudogout as a tumorlike lesion: a case report. 61
21957280 2011
43
Gout and coexisting pseudogout in the knee joint. 61
20802996 2011
44
Manual labor metacarpophalangeal arthropathy in a truck driver: a case report. 61
22027112 2010
45
Pseudogout of the first metatarsophalangeal joint associated with hallux valgus: an atypical bilateral case. 61
20237366 2010
46
Tumoral calcium pyrophosphate dihydrate crystal deposition disease: a rare diagnosis by fine-needle aspiration. 61
19688761 2010
47
Familial hypocalciuric hypercalcemia revealed by chondrocalcinosis. 61
19467900 2009
48
An idiopathic case of calcium pyrophosphate dihydrate crystal deposition disease with crowned dens syndrome in a young patient. 61
19668044 2009
49
An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease. 61
19398486 2009
50
The CPPDD-associated ANKH M48T mutation interrupts the interaction of ANKH with the sodium/phosphate cotransporter PiT-1. 61
19369455 2009

Variations for Familial Calcium Pyrophosphate Deposition

ClinVar genetic disease variations for Familial Calcium Pyrophosphate Deposition:

6 (show top 50) (show all 198) ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 ANKH NM_054027.6(ANKH):c.1165G>A (p.Gly389Arg)SNV Pathogenic 5192 rs28939080 5:14713753-14713753 5:14713644-14713644
2 ANKH NM_054027.6(ANKH):c.143T>C (p.Met48Thr)SNV Pathogenic 5195 rs121908407 5:14769254-14769254 5:14769145-14769145
3 ANKH ANKH, -11C-TSNV Pathogenic 5196
4 ANKH NM_054027.6(ANKH):c.14C>T (p.Pro5Leu)SNV Pathogenic 5198 rs121908409 5:14871543-14871543 5:14871434-14871434
5 ANKH NM_054027.6(ANKH):c.13C>A (p.Pro5Thr)SNV Pathogenic 5199 rs121908410 5:14871544-14871544 5:14871435-14871435
6 ANKH NM_054027.6(ANKH):c.1141+5A>GSNV Conflicting interpretations of pathogenicity 199179 rs187972211 5:14716810-14716810 5:14716701-14716701
7 ANKH NM_054027.6(ANKH):c.1000C>G (p.Leu334Val)SNV Conflicting interpretations of pathogenicity 904041 5:14741947-14741947 5:14741838-14741838
8 ANKH NM_054027.6(ANKH):c.937G>A (p.Val313Met)SNV Uncertain significance 904042 5:14742010-14742010 5:14741901-14741901
9 ANKH NM_054027.6(ANKH):c.897G>A (p.Val299=)SNV Uncertain significance 904824 5:14745997-14745997 5:14745888-14745888
10 ANKH NM_054027.6(ANKH):c.600C>T (p.Gly200=)SNV Uncertain significance 904225 5:14751265-14751265 5:14751156-14751156
11 ANKH NM_054027.6(ANKH):c.*2017G>ASNV Uncertain significance 906055 5:14709289-14709289 5:14709180-14709180
12 ANKH NM_054027.6(ANKH):c.*1894T>CSNV Uncertain significance 907063 5:14709412-14709412 5:14709303-14709303
13 ANKH NM_054027.6(ANKH):c.*1772C>TSNV Uncertain significance 903685 5:14709534-14709534 5:14709425-14709425
14 ANKH NM_054027.6(ANKH):c.*1754G>ASNV Uncertain significance 903686 5:14709552-14709552 5:14709443-14709443
15 ANKH NM_054027.6(ANKH):c.*1753C>TSNV Uncertain significance 903687 5:14709553-14709553 5:14709444-14709444
16 ANKH NM_054027.6(ANKH):c.*1646A>GSNV Uncertain significance 905607 5:14709660-14709660 5:14709551-14709551
17 ANKH NM_054027.6(ANKH):c.*1490T>CSNV Uncertain significance 905608 5:14709816-14709816 5:14709707-14709707
18 ANKH NM_054027.6(ANKH):c.*1470G>ASNV Uncertain significance 905609 5:14709836-14709836 5:14709727-14709727
19 ANKH NM_054027.6(ANKH):c.*1451T>CSNV Uncertain significance 906120 5:14709855-14709855 5:14709746-14709746
20 ANKH NM_054027.6(ANKH):c.*1423G>ASNV Uncertain significance 906121 5:14709883-14709883 5:14709774-14709774
21 ANKH NM_054027.6(ANKH):c.*1372C>ASNV Uncertain significance 906122 5:14709934-14709934 5:14709825-14709825
22 ANKH NM_054027.6(ANKH):c.*1137A>CSNV Uncertain significance 903766 5:14710169-14710169 5:14710060-14710060
23 ANKH NM_054027.6(ANKH):c.*999T>CSNV Uncertain significance 905680 5:14710307-14710307 5:14710198-14710198
24 ANKH NM_054027.6(ANKH):c.*833T>CSNV Uncertain significance 906192 5:14710473-14710473 5:14710364-14710364
25 ANKH NM_054027.6(ANKH):c.*700G>ASNV Uncertain significance 903843 5:14710606-14710606 5:14710497-14710497
26 ANKH NM_054027.6(ANKH):c.*309G>CSNV Uncertain significance 906253 5:14710997-14710997 5:14710888-14710888
27 ANKH NM_054027.6(ANKH):c.*256G>ASNV Uncertain significance 907247 5:14711050-14711050 5:14710941-14710941
28 ANKH NM_054027.6(ANKH):c.*147T>ASNV Uncertain significance 907248 5:14711159-14711159 5:14711050-14711050
29 ANKH NM_054027.6(ANKH):c.*96T>CSNV Uncertain significance 907249 5:14711210-14711210 5:14711101-14711101
30 ANKH NM_054027.6(ANKH):c.*30C>TSNV Uncertain significance 903904 5:14711276-14711276 5:14711167-14711167
31 ANKH NM_054027.6(ANKH):c.*6006A>TSNV Uncertain significance 904414 5:14705300-14705300 5:14705191-14705191
32 ANKH NM_054027.6(ANKH):c.*5980C>ASNV Uncertain significance 904415 5:14705326-14705326 5:14705217-14705217
33 ANKH NM_054027.6(ANKH):c.*5930C>TSNV Uncertain significance 905213 5:14705376-14705376 5:14705267-14705267
34 ANKH NM_054027.6(ANKH):c.*5906T>CSNV Uncertain significance 905214 5:14705400-14705400 5:14705291-14705291
35 ANKH NM_054027.6(ANKH):c.*5900T>CSNV Uncertain significance 905215 5:14705406-14705406 5:14705297-14705297
36 ANKH NM_054027.6(ANKH):c.*5899A>GSNV Uncertain significance 906804 5:14705407-14705407 5:14705298-14705298
37 ANKH NM_054027.6(ANKH):c.*5887G>CSNV Uncertain significance 907799 5:14705419-14705419 5:14705310-14705310
38 ANKH NM_054027.6(ANKH):c.*5062A>GSNV Uncertain significance 905264 5:14706244-14706244 5:14706135-14706135
39 ANKH NM_054027.6(ANKH):c.*4982T>CSNV Uncertain significance 906862 5:14706324-14706324 5:14706215-14706215
40 ANKH NM_054027.6(ANKH):c.*4811A>GSNV Uncertain significance 906863 5:14706495-14706495 5:14706386-14706386
41 ANKH NM_054027.6(ANKH):c.*4777C>ASNV Uncertain significance 906864 5:14706529-14706529 5:14706420-14706420
42 ANKH NM_054027.6(ANKH):c.*4635A>CSNV Uncertain significance 907853 5:14706671-14706671 5:14706562-14706562
43 ANKH NM_054027.6(ANKH):c.*4610C>ASNV Uncertain significance 904540 5:14706696-14706696 5:14706587-14706587
44 ANKH NM_054027.6(ANKH):c.*6368G>ASNV Uncertain significance 906739 5:14704938-14704938 5:14704829-14704829
45 ANKH NM_054027.6(ANKH):c.*6235G>ASNV Uncertain significance 906740 5:14705071-14705071 5:14704962-14704962
46 ANKH NM_054027.6(ANKH):c.*5579G>ASNV Uncertain significance 905262 5:14705727-14705727 5:14705618-14705618
47 ANKH NM_054027.6(ANKH):c.*3752G>ASNV Uncertain significance 904617 5:14707554-14707554 5:14707445-14707445
48 ANKH NM_054027.6(ANKH):c.*3567G>CSNV Uncertain significance 905921 5:14707739-14707739 5:14707630-14707630
49 ANKH NM_054027.6(ANKH):c.*3562G>TSNV Uncertain significance 905922 5:14707744-14707744 5:14707635-14707635
50 ANKH NM_054027.6(ANKH):c.*3554C>TSNV Uncertain significance 907991 5:14707752-14707752 5:14707643-14707643

Expression for Familial Calcium Pyrophosphate Deposition

Search GEO for disease gene expression data for Familial Calcium Pyrophosphate Deposition.

Pathways for Familial Calcium Pyrophosphate Deposition

GO Terms for Familial Calcium Pyrophosphate Deposition

Sources for Familial Calcium Pyrophosphate Deposition

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....